GILD

Gilead Sciences

$117.99

-0.38 (-0.32%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 19.08.2025
$122.39
(+3.73%)
Strong Buy: 3
Buy: 16
Hold: 10
Sell: 0
Strong Sell: 0
Description:
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.
Exchange:
NASDAQ
Country:
USA
Sector:
LIFE SCIENCES
Industry:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Address:
333 LAKESIDE DR, FOSTER CITY, CA, US
Fiscal year end:
December
Market capitalization:
$147 Billion
EBITDA:
$13.8 Billion
PERatio:
23.49
EPS:
5.04
Dividend per share:
$3.12
Dividend yield:
2.62%
Beta:
0.347

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 10 years:
+35%
How much will you get:
$1,348
Prices dates:
31-07-2015: $83.28 and 31-07-2025: $112.29